CANRENONE for Cardiovascular disorder: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 8 adverse event reports in the FDA FAERS database where CANRENONE was used for Cardiovascular disorder.
Most Reported Side Effects for CANRENONE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Hyperkalaemia | 68 | 23.8% | 0 | 50 |
| Hyponatraemia | 35 | 12.2% | 0 | 29 |
| Hypotension | 33 | 11.5% | 0 | 29 |
| Sopor | 25 | 8.7% | 0 | 25 |
| Dehydration | 24 | 8.4% | 0 | 23 |
| Syncope | 23 | 8.0% | 0 | 13 |
| Drug interaction | 21 | 7.3% | 0 | 16 |
| Bradycardia | 19 | 6.6% | 0 | 19 |
| Drug ineffective | 19 | 6.6% | 1 | 11 |
| Renal failure | 19 | 6.6% | 0 | 17 |
| Asthenia | 18 | 6.3% | 0 | 15 |
| Off label use | 18 | 6.3% | 10 | 15 |
| Acute kidney injury | 17 | 5.9% | 0 | 16 |
| Vomiting | 17 | 5.9% | 0 | 16 |
| Drug abuse | 16 | 5.6% | 0 | 16 |
Other Indications for CANRENONE
Hypertension (81)
Product used for unknown indication (78)
Cardiac failure (28)
Covid-19 (9)
Intentional self-injury (8)
Oedema (6)
Drug abuse (5)
Product administration error (5)
Other Drugs Used for Cardiovascular disorder
EVOLOCUMAB (669)
ASPIRIN (304)
ATORVASTATIN (172)
CLOPIDOGREL BISULFATE (121)
TICAGRELOR (110)
METOPROLOL (104)
BOCOCIZUMAB (103)
INVESTIGATIONAL PRODUCT (83)
SEMAGLUTIDE (78)
FUROSEMIDE (76)